Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.
Market competition is not intense. Merck, Ferring, MSD, LIVZON, Abbott, Bayer Zydus Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
North America is the largest consumption place, with a consumption market share nearly 44% in 2017. Following North America, Asia Pacific is the second largest consumption place with the consumption market share of 25%.
Infertility Drugs is widely used for males and females. The most proportion of Infertility Drugs is used for females, and the revenue in 2017 is 89%.
According to this study, over the next five years the Infertility Drugs market will register a 5.2% CAGR in terms of revenue, the global market size will reach US$ 5310 million by 2024, from US$ 4120 million in 2019. In particular, this report presents the global revenue market share of key companies in Infertility Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Infertility Drugs market by product type, application, key companies and key regions.
This study considers the Infertility Drugs value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Gonadotropins
Anti-Estrogens
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Male
Female
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Merck
Ferring
MSD
LIVZON
Abbott
Bayer Zydus Pharma
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Infertility Drugs market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Infertility Drugs market by identifying its various subsegments.
Focuses on the key global Infertility Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Infertility Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Infertility Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
